Table 8 Compared baseline characteristics of the CardioBBEAT, TIM-HF and INH study participants
Variable | CardioBBEAT | TIM-HF | INH | |||
|---|---|---|---|---|---|---|
Usual care | Monitoring | Usual care | Monitoring | Usual care | Monitoring | |
(n = 319) | (n = 302) | (n = 356) | (n = 354) | (n = 363) | (n = 352) | |
Demographic profile | ||||||
Age (years) | 63.5 ± 11.4 | 62.5 ± 11.6 | 66.9 ± 10.5 | 66.9 ± 10.8 | 69.4 ± 11.5 | 67.7 ± 12.8 |
Male sex (%) | 88 | 87 | 82 | 81 | 71 | 71 |
Living alone (%) | 24 | 27 | 22 | 21 | 35 | 30 |
Clinical profile | ||||||
NYHA class (%) | ||||||
I | 0 | 0 | 0 | 0 | 2 | 3 |
II | 65 | 73 | 51 | 50 | 62 | 54 |
III | 34 | 26 | 49 | 50 | 31 | 40 |
IV | 1 | 1 | 0 | 0 | 5 | 3 |
Risk factor profile | ||||||
BMI (kg/m2) | 28 ± 5 | 28 ± 5 | 28 ± 5 | 28 ± 5 | n.a. | n.a. |
Diabetes mellitus (%) | 32 | 38 | 39 | 40 | 36 | 36 |
Hypertension (%) | 84 | 87 | 66 | 68 | 77 | 72 |
Diagnostic | ||||||
Heart rate (1/min) | 72 ± 14 | 72 ± 13 | 71 ± 13 | 71 ± 13 | 80 ± 18 | 80 ± 20 |
LVEF (%) | 31 ± 7 | 30 ± 8 | 27 ± 6 | 27 ± 6 | 30 ± 8 | 30 ± 8 |
Medication (%) | ||||||
ACE inhibitor/ARB | 93 | 93 | 97 | 94 | 87 | 89 |
Beta blocker | 95 | 96 | 93 | 92 | 79 | 81 |
Diuretics | 80 | 83 | 94 | 94 | 86 | 90 |